Novilytic is a molecular recognition company that utilizes nanotechnology to monitor the quality of lifesaving medicines.
Novilytic has raised $531K in total funding. The most recent round was Undisclosed. The last funding was announced in December 2025.
Novilytic's investors include Elevate Ventures, Purdue Foundry, Stateline Angels.
Novilytic is headquartered in West Lafayette, United States.
Novilytic is a molecular recognition company that utilizes nanotechnology to monitor the quality of lifesaving medicines.
Novilytic is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Novilytic — Funding & Investors." VCBacked, December 15, 2025, https://www.vcbacked.co/company/novilytic. Accessed September 29, 2026.
VCBacked. (2025). Novilytic — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/novilytic
{{cite web |title=Novilytic — Funding & Investors |url=https://www.vcbacked.co/company/novilytic |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated